Expected Timeline definition

Expected Timeline has the meaning set forth in Section 1.1.
Sample 1

Examples of Expected Timeline in a sentence

  • U.S. Congress, House Committee on Ways and Means, Expected Timeline for Economic Impact Payments, 116th Cong., April 16, 2020, at https://waysandmeans.house.gov/sites/democrats.waysandmeans.house.gov/files/documents/ 2020.04.16%20Rebate%20Payment%20Timeline%20FINAL.pdf.

  • The effect of this circular is, that where the applicant is a Crown authority and the development is for Educational Services, no contributions should be collected for open space, community facilities, parking, and general local and main road upgrades.

  • Expected Timeline of Progress towards Degrees‌All requirements for the MSW/Ph.D. degree must be completed within ten years.

  • Products maintaining beyond-use dating of greater than thirty (30) days shall have lab testing of product stability and potency.

  • OASAS reserves the right not to open proposals that are received later than the date and time listed in the Expected Timeline for Key Events.

  • Results to Date—Outputs/Outcomes Clean Energy Fund:Clean Transportation Chapter Portfolio: Innovation and ResearchElectric Vehicles—Innovation Expected Timeline Of Funding Commitments(formerly Electric Vehicles, I&R Portfolio) 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Start EndResults to Date - MetricsSummary of Performance and Future Plans This initiative is performing well in terms of attracting participants.

  • The proposal was received by the date and time listed in the Expected Timeline for Key Events.

  • Duration and Expected Timeline of the Assignment: The duration of the assignment would be maximum 36 days and expected to be completed by end of 20th Aug 2019; essentially the assignment has to be started up as soon as the contract process is completed.

  • Expected Timeline of Progress towards DegreesAll requirements for the Ph.D. degree must be completed within eight years for students entering with MSW degrees, and ten years for those without MSW degrees.

  • Program continuing per April 2019 investment plan.Commercial Transition Expected Timeline Of Funding Commitments2016 2017 2018 2019 2020 2021 2022 2023 2024 2025Results to Date - Metrics Start End Summary of Performance and Future PlansThe Commercial Implementation Assistance component of this program closed April 2017.

Related to Expected Timeline

  • Adverse reaction means an unexpected outcome that threatens the health or safety of a patient as a result of a medical service, nursing service, or health-related service provided to the patient.

  • Serious Adverse Event means any adverse event that led to any of the following:

  • Basic generation service or "BGS" means electric generation

  • Regulatory Disruption Any event that Dealer, based on the advice of counsel, determines makes it reasonably necessary or appropriate with regard to any legal, regulatory or self-regulatory requirements or related policies and procedures that generally apply to transactions of a nature and kind similar to the Transaction and have been adopted in good faith by Dealer for Dealer to refrain from or decrease any market activity in connection with the Transaction. Settlement:

  • Development Candidate means a Compound that meets the Development Candidate Criteria for the initiation of a Development Program for the treatment of CF, and which is the subject of a notice from Vertex to CFFT that Vertex intends to commence formal pre-clinical development of the Compound in the Field pursuant to the provisions of Section 3.1 hereof.

  • Price Source Disruption means (a) the failure of the Price Source to announce or publish the Reference Price (or the information necessary for determining the Reference Price); or (b) the temporary or permanent discontinuance or unavailability of the Price Source.

  • Potential Material Event means any of the following: (i) the possession by the Company of material information not ripe for disclosure in the Registration Statement, which shall be evidenced by determinations in good faith by the Board of Directors of the Company that disclosure of such information in the Registration Statement would be detrimental to the business and affairs of the Company, or (ii) any material engagement or activity by the Company which would, in the good faith determination of the Board of Directors of the Company, be adversely affected by disclosure in the Registration Statement at such time, which determination shall be accompanied by a good faith determination by the Board of Directors of the Company that the Registration Statement would be materially misleading absent the inclusion of such information.

  • Target Population means persons with low incomes who have one or more disabilities, including mental illness, HIV or AIDS, substance abuse, or other chronic health condition, or individuals eligible for services provided pursuant to the Lanterman Developmental Disabilities Services Act (Division 4.5 (commencing with Section 4500) of the Welfare and Institutions Code) and may include, among other populations, adults, emancipated minors, families with children, elderly persons, young adults aging out of the foster care system, individuals exiting from institutional settings, veterans, and homeless people.

  • Commercial cannabis activity means the production, cultivation,

  • Small disadvantaged business concern , as used in this clause, means a small business concern that (1) is at least 51 percent unconditionally owned by one or more individuals who are both socially and economically disadvantaged, or a publicly owned business having at least 51 percent of its stock unconditionally owned by one or more socially and economically disadvantaged individuals, and (2) has its management and daily business controlled by one or more such individuals. This term also means a small business concern that is at least 51 percent unconditionally owned by an economically disadvantaged Indian tribe or Native Hawaiian Organization, or a publicly owned business having at least 51 percent of its stock unconditionally owned by one or more of these entities, which has its management and daily business controlled by members of an economically disadvantaged Indian tribe or Native Hawaiian Organization, and which meets the requirements of 13 CFR 124.

  • Pivotal Clinical Trial means, with respect to a Licensed Product, (a) a phase 3 Clinical Trial or (b) any other clinical trial that is intended (as of the time the study is initiated) to obtain the results and data to support (without the need to conduct any additional clinical trial) the filing of an application for Regulatory Approval for such product.